Salivary anti-Helicobacter pylori positivity among endoscopy patients with chronic liver disease
AbstractIn this study, endoscopy patients with and without chronic liver disease [CLD] were examined and tested for Helicobacter pylori infection by detecting the presence of serum and salivary anti-H. pylori antibody. The validity of these measures was compared with Campylobacter-like organism analysis [gold standard] performed on patients requiring gastric biopsy. Among 114 patients with CLD and 50 without, the commonest endoscopy diagnosis was gastritis [27.2%]. Salivary H. pylori positivity was significantly associated with older age. Salivary anti-H. pylori antibody positivity showed low sensitivity [36.6%] and high specificity [75.8%] in CLD patients
Feteih, R., Abdel Salam, M., Jamjoom, H. & Akbar, H. (2009). Salivary anti-Helicobacter pylori positivity among endoscopy patients with chronic liver disease. EMHJ - Eastern Mediterranean Health Journal, 15 (6), 1371-1378, 2009 http://www.who.int/iris/handle/10665/117773
JournalEMHJ - Eastern Mediterranean Health Journal, 15 (6), 1371-1378, 2009
MetadataShow full item record
Showing items related by title and MeSH subject.
Alimohammadi, H.; Fouladi, N.; Salehzadeh, F.; Alipour, S.A.; Javadi, M.S. (2016-12)We examined the role of Helicobacter pylori infection as a cause of recurrent abdominal pain [RAP] among Iranian children in a population-based case-control study to determine the association between H. pylori infection and RAP among schoolchildren. A total of 1558 children aged 6-13 years were examined. Children with RAP confirmed by the Apley and Naish criteria were selected; 145 cases were selected for inclusion and were compared with 145 healthy children recruited from the same area. Both groups underwent stool antigen testing. The prevalence ...